Bruzual-Lezama M C, Peña-Urbina P, Berrozpe-Villabona C, Ibáñez-Flores N
Dra. Carolina Bruzual Clinic, Seville, Spain.
Oculoplastics Department, Instituto Catalán de Retina, C/Cerignola 14, 08017, Barcelona, Spain.
Int Ophthalmol. 2025 May 9;45(1):187. doi: 10.1007/s10792-025-03563-w.
To investigate the correlation between contrast sensitivity changes and post-surgical improvement in visual function perception and health-related quality of life among patients with blepharoptosis.
This prospective cohort studied 55 patients with blepharoptosis surgical indication, one eye per patient was considered for analysis. Refraction, visual acuity (VA), eyelash ptosis and contrast sensitivity (CS) test were evaluated. The National Eye Institute Visual Functioning Questionnaire-25 (NEI-VFQ25), concerning vision-related activities and symptoms, was used to assess the patient´s quality of life pre and postoperatively. Patients were analyzed globally and divided according to the severity of ptosis, lens opacity and the co-existence of glaucoma.
55 eyes underwent ptosis surgery. VA significantly improved without notable refractive changes (p = 0.0044). CS demonstrated significant enhancement in all patients and groups. The NEI-VFQ 25 overall score significantly improved from baseline to 3 months postoperatively (p < 0.001). General vision (p = 0.0319), near and peripheral vision (p < 0.001 and p = 0.0188, respectively), color vision (0.0177), ocular pain (p < 0.001), dependence (p = 0.0093) and mental health (p = 0.0341) exhibited significant improvement. All groups experienced a significant increase in the overall score postoperatively. They all concurred on the improvement of the subscale near vision, except for the glaucoma group, which showed no improvement in either of the subscales.
Ptosis surgery significantly improves contrast sensitivity, visual function, and quality of life in patients, including those with ocular comorbidities such as lens opacity and glaucoma. NEI-VFQ 25 assessment revealed an important enhancement in near and peripheral vision, ocular pain, and dependence; which highlight the broad benefits of the surgery, increasing autonomy in daily activities.
探讨睑下垂患者对比敏感度变化与术后视觉功能感知及健康相关生活质量改善之间的相关性。
本前瞻性队列研究纳入了55例有睑下垂手术指征的患者,每位患者仅分析一只眼。评估了屈光、视力(VA)、上睑下垂和对比敏感度(CS)测试。使用美国国立眼科研究所视觉功能问卷-25(NEI-VFQ25),该问卷涉及与视力相关的活动和症状,用于评估患者术前和术后的生活质量。对患者进行整体分析,并根据上睑下垂的严重程度、晶状体混浊情况以及青光眼的并存情况进行分组。
55只眼接受了上睑下垂手术。视力显著提高,屈光无明显变化(p = 0.0044)。所有患者和组的对比敏感度均显著增强。NEI-VFQ 25总分从基线到术后3个月显著改善(p < 0.001)。一般视力(p = 0.0319)、近视力和周边视力(分别为p < 0.001和p = 0.0188)、色觉(0.0177)、眼痛(p < 0.001)、依赖程度(p = 0.0093)和心理健康(p = 0.0341)均有显著改善。所有组术后总分均显著增加。除青光眼组外,所有组在近视力子量表方面均有改善,而青光眼组在两个子量表中均未显示出改善。
睑下垂手术显著改善了患者的对比敏感度、视觉功能和生活质量,包括那些患有眼部合并症如晶状体混浊和青光眼的患者。NEI-VFQ 25评估显示近视力和周边视力、眼痛及依赖程度有重要改善;这突出了手术的广泛益处,增加了日常活动的自主性。